• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者中的坏疽性脓皮病:一项描述性队列研究。

Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

作者信息

Weizman Adam V, Huang Brian, Targan Stephan, Dubinsky Marla, Fleshner Phillip, Kaur Manreet, Ippoliti Andrew, Panikkath Deepa, Vasiliauskas Eric, Shih David, McGovern Dermot P B, Melmed Gil Y

出版信息

J Cutan Med Surg. 2014 Oct;18(5):361.

PMID:25277124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5089702/
Abstract

BACKGROUND

Pyoderma gangrenosum (PG) is a severe extraintestinal manifestation of inflammatory bowel disease (IBD).

OBJECTIVE

To better characterize PG features and management among an IBD cohort.

METHODS

Subjects with PG were identified using a large database at a tertiary center. Patient demographics and clinical characteristics were summarized using descriptive statistics.

RESULTS

Eighty patients with an episode(s) of PG were identified, yielding an overall prevalence of 1.9%. Overall, 93% of patients with PG had some degree of colonic inflammation. Thirty-one (39%) patients required hospitalization for PG. Underlying bowel disease was active at the time of PG episode(s) in 52 (65%) patients. The PG location was variable, with the lower extremity being the most common. Most patients (71.3%) required multiple therapies to achieve PG healing.

CONCLUSIONS

We describe one of the largest case series of PG among patients with IBD. The variety of treatment strategies used highlights the lack of clear guidelines in managing this complex group of patients.

摘要

背景

坏疽性脓皮病(PG)是炎症性肠病(IBD)的一种严重肠外表现。

目的

更好地描述IBD队列中PG的特征及管理情况。

方法

利用一家三级中心的大型数据库识别出患有PG的受试者。使用描述性统计方法总结患者的人口统计学和临床特征。

结果

识别出80例有PG发作的患者,总体患病率为1.9%。总体而言,93%的PG患者有一定程度的结肠炎症。31例(39%)患者因PG需要住院治疗。52例(65%)患者在PG发作时潜在的肠道疾病处于活动期。PG的发病部位各不相同,下肢最为常见。大多数患者(71.3%)需要多种治疗才能实现PG愈合。

结论

我们描述了IBD患者中最大的PG病例系列之一。所采用的各种治疗策略凸显了在管理这一复杂患者群体方面缺乏明确的指南。

相似文献

1
Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.炎症性肠病患者中的坏疽性脓皮病:一项描述性队列研究。
J Cutan Med Surg. 2014 Oct;18(5):361.
2
Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.炎症性肠病患者中的坏疽性脓皮病:一项描述性队列研究。
J Cutan Med Surg. 2015 Mar-Apr;19(2):125-31. doi: 10.2310/7750.2014.14053. Epub 2015 Mar 11.
3
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
4
[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].[生物疗法在炎症性肠病肠外表现及并发症治疗中的作用]
Acta Med Croatica. 2013 Apr;67(2):195-201.
5
Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy.系统评价:生物制剂时代中与 IBD 相关的坏疽性脓皮病,对治疗的反应。
Aliment Pharmacol Ther. 2013 Sep;38(6):563-72. doi: 10.1111/apt.12431. Epub 2013 Aug 5.
6
Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.与炎症性肠病患者的坏疽性脓皮病和结节性红斑相关的临床、血清学和遗传因素。
Inflamm Bowel Dis. 2014 Mar;20(3):525-33. doi: 10.1097/01.MIB.0000442011.60285.68.
7
Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum.溃疡性结肠炎相关性坏疽性脓皮病与特发性坏疽性脓皮病的临床特征比较。
Chin Med J (Engl). 2017 Nov 20;130(22):2674-2679. doi: 10.4103/0366-6999.218004.
8
Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.与炎症性肠病相关的坏疽性脓皮病的临床表现。
Isr Med Assoc J. 2004 Feb;6(2):88-90.
9
Pyoderma gangrenosum as a first presentation of inflammatory bowel disease.坏疽性脓皮病作为炎症性肠病的首发表现。
BMJ Case Rep. 2014 Nov 9;2014:bcr2014204853. doi: 10.1136/bcr-2014-204853.
10
Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.坏疽性脓皮病:103 例患者的回顾性分析,包括患者特征、合并症和治疗。
Br J Dermatol. 2011 Dec;165(6):1244-50. doi: 10.1111/j.1365-2133.2011.10565.x.

引用本文的文献

1
Pyoderma gangrenosum, peripheral ulcerative keratitis, and oral ulcers in a patient with inflammatory bowel disease.一名炎症性肠病患者出现坏疽性脓皮病、周边溃疡性角膜炎和口腔溃疡。
JAAD Case Rep. 2025 Apr 26;61:78-81. doi: 10.1016/j.jdcr.2025.04.013. eCollection 2025 Jul.
2
Unveiling the Uncommon: Pyoderma Gangrenosum as an Extraintestinal Complication of Ulcerative Colitis.揭示罕见病例:坏疽性脓皮病作为溃疡性结肠炎的肠外并发症
ACG Case Rep J. 2025 Apr 16;12(4):e01675. doi: 10.14309/crj.0000000000001675. eCollection 2025 Apr.
3
Successful Outcome Treating Pyoderma Gangrenosum and Pouchitis With Upadacitinib.使用乌帕替尼成功治疗坏疽性脓皮病和袋炎
ACG Case Rep J. 2024 Aug 10;11(8):e01442. doi: 10.14309/crj.0000000000001442. eCollection 2024 Aug.
4
From guts to skin; unmasking risk factors of pyoderma gangrenosum among Crohn's disease patients.从肠道到皮肤:揭示克罗恩病患者中坏疽性脓皮病的危险因素
Arch Dermatol Res. 2024 Jul 5;316(7):450. doi: 10.1007/s00403-024-03119-5.
5
What can inherited immunodeficiencies reveal about pyoderma gangrenosum?遗传性免疫缺陷病能揭示坏疽性脓皮病的哪些问题?
Exp Dermatol. 2024 Jan;33(1):e14954. doi: 10.1111/exd.14954. Epub 2023 Oct 17.
6
Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中坏疽性脓皮病的治疗
JPGN Rep. 2020 Aug 21;1(2):e008. doi: 10.1097/PG9.0000000000000008. eCollection 2020 Nov.
7
Dual Biologic Therapy in an Adolescent With Camurati-Engelmann Disease and Crohn Disease.一名患有卡穆拉蒂-恩格尔曼病和克罗恩病的青少年的双重生物疗法
JPGN Rep. 2022 Jan 24;3(1):e169. doi: 10.1097/PG9.0000000000000169. eCollection 2022 Feb.
8
Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report.溃疡性结肠炎患者接种新冠疫苗引发坏疽性脓皮病:一例报告
Int J Low Extrem Wounds. 2022 Nov 25:15347346221141173. doi: 10.1177/15347346221141173.
9
Crohn's Disease Diagnosed in a Man with Sarcoidosis: Coincidence or Correspondence?一名患有结节病的男性被诊断出克罗恩病:巧合还是相关?
Case Rep Gastrointest Med. 2022 May 27;2022:5943468. doi: 10.1155/2022/5943468. eCollection 2022.
10
Perineal pyoderma gangrenosum in pregnancy: A case report.妊娠期会阴部坏疽性脓皮病:一例报告。
Case Rep Womens Health. 2019 Mar 7;22:e00102. doi: 10.1016/j.crwh.2019.e00102. eCollection 2019 Apr.

本文引用的文献

1
Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.免疫介导的炎症反应和肿瘤作为炎症性肠病治疗的皮肤副作用。
Autoimmunity. 2014 May;47(3):146-53. doi: 10.3109/08916934.2013.873414. Epub 2014 Jan 20.
2
Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.炎症性肠病患者的皮肤表现:发病机制、临床特征和治疗。
Inflamm Bowel Dis. 2014 Jan;20(1):213-27. doi: 10.1097/01.MIB.0000436959.62286.f9.
3
Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy.系统评价:生物制剂时代中与 IBD 相关的坏疽性脓皮病,对治疗的反应。
Aliment Pharmacol Ther. 2013 Sep;38(6):563-72. doi: 10.1111/apt.12431. Epub 2013 Aug 5.
4
Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases.抗 TNF-α 治疗炎症性肠病过程中诱导或加重银屑病皮损:基于 222 例的系统文献复习。
J Crohns Colitis. 2013 Aug;7(7):517-24. doi: 10.1016/j.crohns.2012.08.007. Epub 2012 Sep 7.
5
Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.需住院治疗的坏疽性脓皮病:26 例病例报告及随访。
Australas J Dermatol. 2011 Aug;52(3):218-21. doi: 10.1111/j.1440-0960.2011.00750.x. Epub 2011 Jul 20.
6
Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.坏疽性脓皮病:103 例患者的回顾性分析,包括患者特征、合并症和治疗。
Br J Dermatol. 2011 Dec;165(6):1244-50. doi: 10.1111/j.1365-2133.2011.10565.x.
7
Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009.炎症性肠病相关性坏疽性脓皮病:1998 年至 2009 年 Mater 卫生服务成人医院的经验。
J Crohns Colitis. 2011 Apr;5(2):148-51. doi: 10.1016/j.crohns.2010.10.006. Epub 2011 Feb 22.
8
Clinical features of pyoderma gangrenosum and current diagnostic trends.坏疽性脓皮病的临床特征和当前的诊断趋势。
J Am Acad Dermatol. 2011 May;64(5):950-4. doi: 10.1016/j.jaad.2010.01.049. Epub 2011 Feb 3.
9
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.瑞士炎症性肠病队列中肠外表现的频率和危险因素。
Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.
10
Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.坏疽性脓皮病:21 例患者的研究及“临床治疗”分类的提出。
J Dermatolog Treat. 2011 Oct;22(5):254-60. doi: 10.3109/09546631003686069. Epub 2010 Jul 28.